Bruner and colleagues describe a comprehensive, long-term research program designed to understand, model, and modify prostate cancer risk. According to the investigators, the main problem with early prostate cancer risk screening is the
Harry Burke, MD, PhD
Advertisement
Articles by Harry Burke, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer
2
Selecting Among Preferred 1L Regimens — A Discussion
3
What is the Future of TIL Therapy in Metastatic Melanoma?
4
Clinical Context & MARIPOSA Efficacy in 1L EGFRm NSCLC
5